Sotera Health Company
Price chart
Anonymous reader poll. Unscientific, not investment advice.
✦ StockVane Quant Insights how this is computed
- Below its 200-day average or in the bottom third on momentum — the strategy is out of it.
- Signal has read SELL for 3 weeks.
- Its last 3 Sell calls were followed by a 8% average decline over the next quarter.
- Recent price momentum is -8.2% on average (3-month/1-year).
- Main-fund capital flow has been a net outflow over the last 45 sessions.
- Short interest has risen to 5.8% of float.
- Analyst tilt is Buy.
- Price is below its 20-day average and below its 60-day average.
- The 20-day average is below the 60-day average, a short-term downtrend.
Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.
Factor grades
Ranked against 2848 U.S. stocks StockVane covers.
Last computed: 2026-11-22 14:27 UTC
Data coverage: 6 of 6 factors. Missing data is not a zero score.
Valuation C+
How expensive the stock is versus earnings, sales and its own 5-year history.
| P/E (TTM) | 26.5x | Better than 27% |
| Forward P/E | 20.4x | Better than 35% |
| Price / Sales | 3.9x | Better than 31% |
| P/E vs own 5-yr range | 27th pctl | Better than 79% |
Growth C
How fast revenue, profit and free cash flow are compounding.
| Revenue CAGR (3Y) | 5.1% | Better than 47% |
| Net income CAGR (3Y) | -27.6% | Better than 12% |
| Free cash flow CAGR (3Y) | 16.0% | Better than 60% |
Profitability B+
How much profit the business keeps from each dollar of sales and capital.
| Gross margin | 55.5% | Better than 70% |
| Operating margin | 31.1% | Better than 90% |
| Net margin | 6.7% | Better than 49% |
| Return on equity | 15.4% | Better than 69% |
| Return on invested capital | 6.9% | Better than 55% |
Momentum B-
Recent price strength, skipping the latest month to avoid short-term noise.
| 3-month return | -18.7% | Better than 33% |
| 6-month return | 1.6% | Better than 59% |
| 12-month return (ex latest month) | 10.8% | Better than 48% |
| Distance below 52-week high | 19.8% | Better than 61% |
Financial Health C+
Balance-sheet strength: leverage, liquidity and interest coverage.
| Current ratio | 2.5x | Better than 66% |
| Debt to assets | 69.7% | Better than 5% |
| Interest coverage | 1.9x | Better than 36% |
| Free cash flow / net income | 191.4% | Better than 75% |
Analyst View B
What the Street thinks: share of Buy ratings and upside to the average target.
| Analysts rating Buy | 83.3% | Better than 63% |
| Upside to average target | 36.2% | Better than 56% |
Grades are relative rankings, not forecasts: A+ is the top 5% of the covered stocks on a factor, F the bottom 3%. Valuation is not adjusted for sector. Background recomputation is scheduled every 6 hours; actual computation time is shown above, and source datasets have different reporting dates. Not investment advice or tailored to your financial situation.
Performance
Key statistics
Price & volume
- Prev close
- 16.21
- Open
- 16.18
- Day range
- 15.81 - 16.34
- Avg price
- 15.92
- Volume
- 1.73M
- Turnover
- 27.57M
- Turnover ratei
- 0.86%
- Volume ratioi
- 0.68
- Amplitudei
- 3.24%
- 52-week rangei
- 13.09 - 19.85
Valuation
- P/Ei
- 58.93
- P/E (TTM)i
- 26.52
- P/Bi
- 6.20
- EPSi
- 0.27
- Book value / shi
- 2.57
- Net profit
- 77.12M
- Net assets
- 733.21M
Share structure
- Market cap
- 4.54B
- Float capi
- 3.21B
- Shares out
- 285.63M
- Float sharesi
- 202.05M
Dividend & listing
- Div yield (TTM)i
- 0.00%
- Dividend (TTM)
- 0.00
- Listing date
- 2020-11-20
19.8% below the 52-week high
Trading activity
Net capital flow main funds, last 45 sessions
-12.49M net over the window
Short interest
- Shares short
- 16.44M
- % of floati
- 5.76%
- Days to coveri
- 7.53
- As of
- 2026-10-30
Frequently asked questions
What is the current stock price of Sotera Health Company (SHC)?
Sotera Health Company last traded at 15.91. This page shows a periodic quote snapshot. Check the displayed quote time.
What is Sotera Health Company's market cap?
About 4.54B.
What is the P/E ratio of Sotera Health Company?
The trailing twelve-month P/E is 26.52, below its own 5-year average of 59.35 — toward the bottom of its historical range (26.87% percentile). See the Valuation tab for the full history.
Does Sotera Health Company pay a dividend?
Sotera Health Company does not currently pay a regular dividend.
Is Sotera Health Company a buy according to analysts?
The consensus of 6 analysts is a Buy rating, with an average 12-month price target of 21.67, which implies 36.2% upside from the current price. This is not investment advice.
What is Sotera Health Company's StockVane Quant Rating?
The StockVane Momentum strategy currently rates Sotera Health Company a D (Sell). Below its 200-day average or in the bottom third on momentum — the strategy is out of it. Not investment advice.
Quote time 2026-11-20 16:00:57 · For reference only, not investment advice and not tailored to your situation.
Sotera Health Company discussion 0 comments